MedPath

Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients

Not Applicable
Completed
Conditions
Fibromyalgia
Interventions
Dietary Supplement: Rice protein
Dietary Supplement: Gluten
Registration Number
NCT03129906
Lead Sponsor
Federal University of Minas Gerais
Brief Summary

The aim of this study is to evaluate the impact of gluten-free diets on symptoms and inflammatory markers in individuals with previous diagnosis of fibromyalgia (FM), as well as to identify the presence of non-celiac gluten sensitivity (NCSG) in individuals with FM. Patients with FM diagnosis will be kept on a gluten-free diet for a 10 weeks. In the 7th week, they will receive placebo capsules for 7 days and after washout, capsules containing gluten for another 7 days. A questionnaire based on Salerno protocol will be applied to evaluate the presence of NCGS in the beginning, 8th week and 10 week.

Detailed Description

Fibromyalgia (FM) is a chronic and widespread pain condition, usually accompanied by several associated symptoms such as fatigue, sleep disorder, headache, irritable bowel syndrome and mood disorders. Recent studies point to the possibility of gluten protein having a role in the development of FM symptoms in a subgroup of patients. Fourteen patients with FM diagnosis will be kept on a diet restrict in gluten-free foods for a period 10 weeks. At the 7th week they received rice protein isolate capsules (placebo) for 7 days, followed by a 3-day wash-out and a new challenge with capsules containing 8 g/day of gluten (corresponding to 6,3g gluten protein) for another 7 days. In the initial period, at 8th week (final of placebo period) and after challenge with gluten (10th week), blood will be collected for analysis of inflammatory markers. Questionnaires will be carried out to evaluate the quantity and severity of FM symptoms and the impact of FM on daily routine. Inflammatory markers (IL-1bera, IL-6 and IL-10) will be evaluated in the blood. In the challenger period (gluten or placebo) questionnaires will be carried out to evaluate the quantity and severity of symptoms related to fibromyalgia and the impact of fibromyalgia on a daily basis. In addition, a questionnaire based on Salerno protocol was applied to evaluate the presence of NCGS.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
26
Inclusion Criteria

• Women between 18 and 65 years of age with prior clinical diagnosis of FM, according to the American College of Rheumatology criteria of 2010

Exclusion Criteria
  • Subjects diagnosed with positive serology for celiac disease or allergy to wheat
  • Subjects diagnosed with autoimmune diseases
  • Subjects with diseases that are not part of the comorbidities associated with FM and t hat could influence the results of the study
  • Pregnant or lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Rice proteinRice proteinCapsules containing 6,4 g/day of rice protein were blindly administered for 7 days
GlutenGlutenCapsules containing 8 g/day of gluten (6,3g of protein) were blindly administered for 7 days
Primary Outcome Measures
NameTimeMethod
Changes in fibromyalgia Symptoms by Salerno protocolBaseline, 4th and 8th weeks, 10th week

Self report of symptoms intensity in the last week. Each item is scored 0 (no symptom) to 10 (very intense symptom).

Secondary Outcome Measures
NameTimeMethod
Changes in body weightBaseline, 8th and 10th weeks

measured in weight in kg

Heightbaseline

measured in meters

changes in BMIBaseline, 8th and 10th weeks

in kg of body weight/square of height

Changes in IL-6 blood concentrationBaseline, 8th and 10th weeks

measure by ELISA in ug/mL

Changes in IL-10 blood concentrationBaseline, 8th and 10th weeks

measure by ELISA in ug/mL

Changes in IL-1beta blood concentrationBaseline, 8th and 10th weeks

measure by ELISA in ug/mL

changes in Food intakeBaseline, 8th and 10th weeks

measured in % of kcal

Trial Locations

Locations (1)

Laboratório de Aterosclerose e Bioquimica Nutricional

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

© Copyright 2025. All Rights Reserved by MedPath